aceAI-ECG for pediatric and congenital heart disease detection and risk stratification
Source article: The electrocardiogram and artificial intelligence: turning signals into insights in pediatric and congenital heart disease
Abstract: Purpose of review Artificial intelligence applied to electrocardiography (AI-ECG) has rapidly been investigated in adult cardiovascular medicine, yet translation into pediatric and congenital heart disease populations has lagged. This review summarizes contemporary AI-ECG methodologies and emerging applications in pediatric and congenital heart disease (PCHD), with emphasis on current clinical utility, technical challenges, and future opportunities for implementation. Recent findings Recent studies demonstrate t…
Positive state: both sides are scored from claims and sources, not community votes.
Cardio surgery 3 by Dominique Cappronnier. CC BY-SA 3.0 · https://creativecommons.org/licenses/by-sa/3.0
This review from August 2026 summarizes how artificial intelligence applied to standard electrocardiograms has been tested in pediatric and congenital heart disease. It reports that deep learning models have been shown to identify arrhythmias, ventricular dysfunction, and CHD, and are being extended to predict future risk and to analyze wearable and telemetry data.
The clinical promise is tempered by the state of the evidence, which remains largely retrospective and single-center without broad external validation. Real-world use will depend on prospective multicenter studies, standardized datasets that account for age-related variation, and resolution of ethical and regulatory questions.
- Review focuses on AI-ECG translation from adult medicine to pediatric and congenital heart disease populations.
- Convolutional neural networks remain dominant, with transformer-based foundation models and self-supervised learning increasingly explored.
- Applications expanded from automated interpretation to proactive risk stratification including ventricular dysfunction, mortality, and sudden cardiac death risk.
- Additional work investigated wearable monitoring, telemetry analysis, and integration with longitudinal clinical data.
Deep learning models applied to standard ECGs can accurately identify arrhythmias, ventricular dysfunction, and congenital heart disease in pediatric populations, supporting earlier detection and risk stratification.
Most AI-ECG studies in pediatric and congenital heart disease remain retrospective and single-center with limited external validation, facing challenges from small datasets and age-dependent ECG variation.
The rundown
The review describes AI-ECG methodologies in PCHD, noting convolutional neural networks as dominant and growing exploration of transformer-based foundation models and self-supervised learning. Recent work moves beyond automated interpretation toward prediction of ventricular dysfunction, mortality, and sudden cardiac death risk, plus wearable and telemetry analysis.
Despite promising retrospective performance, the field faces technical barriers including small datasets, physiologic heterogeneity, and age-dependent ECG variation. The authors state broader implementation will require multicenter collaboration, prospective validation, standardized datasets, and attention to ethical, regulatory, and equity considerations.
Most evidence is retrospective and single-center with limited external validation, constrained by small datasets and age-dependent physiologic heterogeneity.
Sources
- Peer-reviewedCurrent Opinion in Pediatrics2026-08-13
How should this claim be treated?
The debate